NextBioMedical Co Ltd
KOSDAQ:389650
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
NextBioMedical Co Ltd
Accounts Receivables
NextBioMedical Co Ltd
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
N
|
NextBioMedical Co Ltd
KOSDAQ:389650
|
Accounts Receivables
₩2.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Accounts Receivables
₩67.8B
|
CAGR 3-Years
9%
|
CAGR 5-Years
11%
|
CAGR 10-Years
11%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Accounts Receivables
₩48.9B
|
CAGR 3-Years
89%
|
CAGR 5-Years
74%
|
CAGR 10-Years
94%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Accounts Receivables
₩19.4B
|
CAGR 3-Years
1 378%
|
CAGR 5-Years
478%
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Accounts Receivables
₩7.5B
|
CAGR 3-Years
40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Accounts Receivables
₩4.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
NextBioMedical Co Ltd
Glance View
NextBioMedical Co Ltd is a KR-based company operating in Health Care Equipment & Supplies industry. The company is headquartered in Incheon, Incheon. The company went IPO on 2024-08-20. NextBioMedical Co Ltd is a Korea-based company mainly engaged in the manufacturing and sales of medical equipment. The firm is mainly engaged in the manufacturing and sales of medical equipment, such as endoscopic hemostatic agents and vascular embolic microspheres. In addition, the Company is also engaged in the research and development of medical equipment.
See Also
What is NextBioMedical Co Ltd's Accounts Receivables?
Accounts Receivables
2.1B
KRW
Based on the financial report for Dec 31, 2024, NextBioMedical Co Ltd's Accounts Receivables amounts to 2.1B KRW.
What is NextBioMedical Co Ltd's Accounts Receivables growth rate?
Accounts Receivables CAGR 1Y
103%
Over the last year, the Accounts Receivables growth was 103%.
